Evidence map›Paper›PMID 39525023›Full record

ArticleTranslational cancer research2024

Oncogenic role of

Wanxue Hu, Xiaoyi Hu, Yongchao Zhu, Min Li, Hongyu Meng, Hongbo Zhao

Abstract read
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wanxue HuDepartment of Clinical Laboratory, Hua County People's Hospital, Anyang, China.
Xiaoyi HuDepartment of Nursing, Henan Health Cadre College, Zhengzhou, China.
Yongchao ZhuDepartment of Clinical Laboratory, Hua County People's Hospital, Anyang, China.
Min LiDepartment of Clinical Laboratory, Hua County People's Hospital, Anyang, China.
Hongyu MengDepartment of Clinical Laboratory, Hua County People's Hospital, Anyang, China.
Hongbo ZhaoDepartment of Laboratory Animal Science, Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Genetic alterations have important roles in cancer development and progression. Methods: We utilized various databases and bioinformatics tools, such as The Cancer Genome Atlas (TCGA), survminer package, Tumor Immune Estimation Resource (TIMER), cBioPortal website, clusterProfiler package, gene set enrichment analysis (GSEA), miRWalk, TargetScanHuman8.0, miRDB, DIANA and Cytoscape to identify the role of Results: Our results showed that patients with HCC exhibited a high Conclusions:

Indexed as

bioinformatics analysiscompeting endogenous RNA (ceRNA)hepatocellular carcinoma (HCC)Spindle and kinetochore associated complex subunit 2 (SKA2)

Identifiers

PMID39525023
PMCPMC11543042

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.